Clinical Trial Update: Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia

View source ↗

Summary

A pharmacovigilance clinical trial evaluating the safety of AVODART (dutasteride) in men with benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Avodart (dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Benign Prostatic Hyperplasia | Status: COMPLETED